Nallengare Pharmaceuticlas Pvt Ltd

Nallengare Pharmaceuticlas Pvt Ltd - chemicals in Trichur, Kerala, India. FY 2026 financials and compliance.
CIN U24231KL1983PTC003760 Incorporated 21 July 1983 ROC Ernakulam HQ Trichur, Kerala, India
Active Private Limited Company chemicals
Data last updated
Revenue · FY 2025
₹5.66 Lakh
▲ 8.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹8.7 Lakh
Secured borrowings
Company age
43 yrs
Est. 1983
Last financials
Mar 2025
Balance sheet date

About Nallengare Pharmaceuticlas Pvt Ltd

Data last updated: 25 February 2026

Nallengare Pharmaceuticlas Pvt Ltd is a private limited company based in Trichur, Kerala, India. It specialises in chemical products, a part of the broader chemicals sector. Incorporated on 21 July 1983, the company has been in operation for over 43 years.

Registered with ROC Ernakulam under CIN U24231KL1983PTC003760.

Capital: an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Paul Varghese and Milly Varghese.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Xi/336Caico Road Ollur, Trichur, Kerala, India – 680006.

As per the financials filed for FY 2025, the company reported a revenue of ₹5.66 Lakh, a growth of 8% compared to the previous year.

As per MCA filings, the company has open charges of ₹8.7 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Nallengare Pharmaceuticlas Pvt Ltd
CIN U24231KL1983PTC003760
Registration Number 003760
Incorporation Date 21 July 1983
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Xi/336Caico Road Ollur, Trichur, Kerala, India – 680006
  • Industry
    Chemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
Company report
Nallengare Pharmaceuticlas Pvt Ltd - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Nallengare Pharmaceuticlas Pvt Ltd report

Financials, compliance, directors, charges, ownership and filings for Nallengare Pharmaceuticlas Pvt Ltd in one report.

10-year financials Directors & ownership Charges & compliance

Auditor Details of Nallengare Pharmaceuticlas Pvt Ltd

Nallengare Pharmaceuticlas Pvt Ltd is audited by SURENDRANATH ELASSERY for the financial year 2017. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
SURENDRANATH ELASSERY Locked Locked Locked
Premium access

Complete auditor history for Nallengare Pharmaceuticlas Pvt Ltd

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Nallengare Pharmaceuticlas Pvt Ltd

Nallengare Pharmaceuticlas Pvt Ltd is currently managed by 2 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Paul Varghese Managing Director 28 Sep 2010 15 Years 10 Months Current
Milly Varghese Director 21 Jul 1983 43 Years 1 Months Current

Financials of Nallengare Pharmaceuticlas Pvt Ltd FY 2025 filings available

Nallengare Pharmaceuticlas Pvt Ltd reported revenue of ₹5.66 Lakh (up 8.00% YoY) for FY 2025.

Revenue · FY 2025
₹5.66 Lakh ▲ 8.00%
Premium access

Ten-year financial statements for Nallengare Pharmaceuticlas Pvt Ltd

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Nallengare Pharmaceuticlas Pvt Ltd

Premium access

Shareholding and ownership data for Nallengare Pharmaceuticlas Pvt Ltd

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Nallengare Pharmaceuticlas Pvt Ltd

Open charges
₹8.7 Lakh
Satisfied charges
₹0
Breakdown by lending institutions
Sampanna Kuries (P) Ltd₹0.05 Cr
Gampanra Furies (I) Ltd₹0.02 Cr
South Indian Bank Ltd₹0.01 Cr
The South Indian Bank Limited₹0.01 Cr
Federal Bank Ltd₹0.00 Cr
Latest charge details
DateLenderAmountStatus
01 Mar 2001 Sampanna Kuries (P) Ltd ₹4.55 Lakh Open
12 Jul 1988 Gampanra Furies (I) Ltd ₹1.8 Lakh Open
18 Dec 1986 Federal Bank Ltd ₹15,000 Open
29 Apr 1986 South Indian Bank Ltd ₹1.2 Lakh Open
26 Oct 1984 The South Indian Bank Limited ₹1 Lakh Open

Total charge records: 5 View all charges

Employees and EPFO Compliance at Nallengare Pharmaceuticlas Pvt Ltd

View historical data on people associated with Nallengare Pharmaceuticlas Pvt Ltd, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Nallengare Pharmaceuticlas Pvt Ltd

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Nallengare Pharmaceuticlas Pvt Ltd

Premium access

GST registrations and filing compliance for Nallengare Pharmaceuticlas Pvt Ltd

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Nallengare Pharmaceuticlas Pvt Ltd

Premium access

Credit ratings, litigation, and regulatory alerts for Nallengare Pharmaceuticlas Pvt Ltd

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Nallengare Pharmaceuticlas Pvt Ltd

Premium access

MSME payment history for Nallengare Pharmaceuticlas Pvt Ltd

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Nallengare Pharmaceuticlas Pvt Ltd

Premium access

Corporate group structure for Nallengare Pharmaceuticlas Pvt Ltd

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Nallengare Pharmaceuticlas Pvt Ltd

Premium access

MCA filings and documents for Nallengare Pharmaceuticlas Pvt Ltd

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Nallengare Pharmaceuticlas Pvt Ltd

Activity
30 Sep 2025
Nallengare Pharmaceuticlas Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Nallengare Pharmaceuticlas Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Directors
28 Sep 2010
Paul Varghese was appointed as a Managing Director on 28 Sep 2010 & has been associated with this company since 15 years 10 months.
Charges
01 Mar 2001
A charge with Sampanna Kuries (P) Ltd amounted to Rs. 4.55 Lakh with Charge ID 90018148 was registered on 01 Mar 2001.
Charges
12 Jul 1988
A charge with Gampanra Furies (I) Ltd amounted to Rs. 1.80 Lakh with Charge ID 90015677 was registered on 12 Jul 1988.
Charges
18 Dec 1986
A charge with Federal Bank Ltd amounted to Rs. 0.15 Lakh with Charge ID 90015589 was registered on 18 Dec 1986.

Frequently Asked Questions about Nallengare Pharmaceuticlas Pvt Ltd

Nallengare Pharmaceuticlas Pvt Ltd is an active private limited company in the chemicals sector based in Trichur, Kerala, India. It was incorporated on 21 July 1983 (43+ years old) and is registered under CIN U24231KL1983PTC003760.

Nallengare Pharmaceuticlas Pvt Ltd reported revenue of ₹5.66 Lakh for FY 2025 (up 8.00% YoY).

The current directors of Nallengare Pharmaceuticlas Pvt Ltd are:

The primary industry of Nallengare Pharmaceuticlas Pvt Ltd is chemicals. The company specifically operates in chemical products. The company is currently active in this sector.

Nallengare Pharmaceuticlas Pvt Ltd can be reached at the registered office: Xi336Caico Road Ollur, Trichur, Kerala, India – 680006.

The authorised capital is ₹1 Lakh, and the paid-up capital is ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available